Cargando…
Neurological Immunotoxicity from Cancer Treatment
The emergence of immune-based treatments for cancer has led to a growing field dedicated to understanding and managing iatrogenic immunotoxicities that arise from these agents. Immune-related adverse events (irAEs) can develop as isolated events or as toxicities affecting multiple body systems. In p...
Autores principales: | Wesley, Sarah F., Haggiagi, Aya, Thakur, Kiran T., De Jager, Philip L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268562/ https://www.ncbi.nlm.nih.gov/pubmed/34201529 http://dx.doi.org/10.3390/ijms22136716 |
Ejemplares similares
-
Arsenic immunotoxicity: a review
por: Dangleben, Nygerma L, et al.
Publicado: (2013) -
A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements
por: Giannakou, Christina, et al.
Publicado: (2016) -
Mechanisms of Immunotoxicity: Stressors and Evaluators
por: Bou Zerdan, Maroun, et al.
Publicado: (2021) -
Immunotoxicity Considerations for Next Generation Cancer Nanomedicines
por: Hannon, Gary, et al.
Publicado: (2019) -
Exploring the Immunotoxicity of Carbon Nanotubes
por: Yu, Yanmei, et al.
Publicado: (2008)